Alhourani A, Forde J, Nasrollahzadeh M, Eichacker L, Herfindal L, Hagland H
Nanoscale Adv. 2022; 4(6):1668-1680.
PMID: 36134366
PMC: 9417205.
DOI: 10.1039/d1na00778e.
Alhourani A, Forde J, Eichacker L, Herfindal L, Hagland H
ACS Omega. 2021; 6(38):24619-24629.
PMID: 34604644
PMC: 8482513.
DOI: 10.1021/acsomega.1c03283.
Singh A, Gu J, Zhang Q, Torka P, Sundaram S, Mavis C
Cancer Metab. 2020; 8:10.
PMID: 32647571
PMC: 7336499.
DOI: 10.1186/s40170-020-00213-w.
Benjamin D, Colombi M, Hindupur S, Betz C, Lane H, El-Shemerly M
Sci Adv. 2016; 2(12):e1601756.
PMID: 28028542
PMC: 5182053.
DOI: 10.1126/sciadv.1601756.
Matyszewski A, Czarnecka A, Kawecki M, Korzen P, Safir I, Kukwa W
Oncol Lett. 2015; 10(2):589-594.
PMID: 26622538
PMC: 4509084.
DOI: 10.3892/ol.2015.3324.
The Antidiabetic Drug Metformin Stimulates Glycolytic Lactate Production in Cultured Primary Rat Astrocytes.
Westhaus A, Blumrich E, Dringen R
Neurochem Res. 2015; 42(1):294-305.
PMID: 26433380
DOI: 10.1007/s11064-015-1733-8.
Evaluation of antagonistic effects of metformin with Cisplatin in gastric cancer cells.
Lesan V, Ghaffari S, Salaramoli J, Heidari M, Rostami M, Alimoghaddam K
Int J Hematol Oncol Stem Cell Res. 2015; 8(3):12-9.
PMID: 25642303
PMC: 4305376.
Metformin: Current knowledge.
Nasri H, Rafieian-Kopaei M
J Res Med Sci. 2014; 19(7):658-64.
PMID: 25364368
PMC: 4214027.
Metformin and erlotinib synergize to inhibit basal breast cancer.
Lau Y, Du X, Rayannavar V, Hopkins B, Shaw J, Bessler E
Oncotarget. 2014; 5(21):10503-17.
PMID: 25361177
PMC: 4279389.
DOI: 10.18632/oncotarget.2391.
Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.
Welch M, Grommes C
CNS Oncol. 2014; 2(3):237-46.
PMID: 25054464
PMC: 6166491.
DOI: 10.2217/cns.13.12.
Metformin: are potential benefits on cancer risk extended to cancer survival?.
La Vecchia C, Bosetti C
Oncologist. 2013; 18(12):1245-7.
PMID: 24258614
PMC: 3868416.
DOI: 10.1634/theoncologist.2013-0381.
Serine, glycine and one-carbon units: cancer metabolism in full circle.
Locasale J
Nat Rev Cancer. 2013; 13(8):572-83.
PMID: 23822983
PMC: 3806315.
DOI: 10.1038/nrc3557.
Metformin inhibits the growth of human pancreatic cancer xenografts.
Kisfalvi K, Moro A, Sinnett-Smith J, Eibl G, Rozengurt E
Pancreas. 2013; 42(5):781-5.
PMID: 23462329
PMC: 3681894.
DOI: 10.1097/MPA.0b013e31827aec40.
Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
Soares H, Ni Y, Kisfalvi K, Sinnett-Smith J, Rozengurt E
PLoS One. 2013; 8(2):e57289.
PMID: 23437362
PMC: 3578870.
DOI: 10.1371/journal.pone.0057289.
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.
Okwan-Duodu D, Umpierrez G, Brawley O, Diaz R
Am J Cancer Res. 2013; 3(1):21-33.
PMID: 23359288
PMC: 3555202.
Metformin in obesity, cancer and aging: addressing controversies.
Berstein L
Aging (Albany NY). 2012; 4(5):320-9.
PMID: 22589237
PMC: 3384433.
DOI: 10.18632/aging.100455.
Metformin use among individuals at risk for type 2 diabetes.
Kuller L
Curr Diab Rep. 2012; 12(3):265-73.
PMID: 22399368
DOI: 10.1007/s11892-012-0263-x.
Phenformin as prophylaxis and therapy in breast cancer xenografts.
Appleyard M, Murray K, Coates P, Wullschleger S, Bray S, Kernohan N
Br J Cancer. 2012; 106(6):1117-22.
PMID: 22361631
PMC: 3304424.
DOI: 10.1038/bjc.2012.56.
Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression.
Jung J, Park S, Lee S, Seo M, Trosko J, Kang K
PLoS One. 2011; 6(11):e28068.
PMID: 22132214
PMC: 3223228.
DOI: 10.1371/journal.pone.0028068.
Rapamycin passes the torch: a new generation of mTOR inhibitors.
Benjamin D, Colombi M, Moroni C, Hall M
Nat Rev Drug Discov. 2011; 10(11):868-80.
PMID: 22037041
DOI: 10.1038/nrd3531.
